Home
>
National Drug Code (NDC)
>
Methylprednisolone Sodium Succinate
Methylprednisolone Sodium Succinate - 55390-209-10 - (Methylprednisolone Sodium Succinate)
Drug Information of Methylprednisolone Sodium Succinate
| Product NDC: | 55390-209 |
| Proprietary Name: | Methylprednisolone Sodium Succinate |
| Non Proprietary Name: | Methylprednisolone Sodium Succinate |
| Active Ingredient(s): | 40 mg/mL & nbsp; Methylprednisolone Sodium Succinate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Methylprednisolone Sodium Succinate
| Product NDC: | 55390-209 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040662 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070301 |
Package Information of Methylprednisolone Sodium Succinate
| Package NDC: | 55390-209-10 |
| Package Description: | 10 VIAL, SINGLE-DOSE in 1 BOX (55390-209-10) > 1 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Methylprednisolone Sodium Succinate
| NDC Code | 55390-209-10 |
| Proprietary Name | Methylprednisolone Sodium Succinate |
| Package Description | 10 VIAL, SINGLE-DOSE in 1 BOX (55390-209-10) > 1 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 55390-209 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Methylprednisolone Sodium Succinate |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20070301 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | METHYLPREDNISOLONE SODIUM SUCCINATE |
| Strength Number | 40 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
